Omnes Capital and Partech Ventures support the launch of online health advice site mesdocteurs.com
MesDocteurs has completed an initial €1.2 million funding round with Omnes Capital, Partech Ventures and a business angel from the insurance world.
MesDocteurs is a start-up founded in 2015 by Chloé Ramade, Séverine Grégoire and Nicolas Orofino, the founders of Monshowroom, which was supported from its beginnings by Omnes Capital and sold in 2014 to Groupe Casino.
MesDocteurs is a paying service that provides accurate and specific health advice and information. If necessary, it refers the user to a healthcare professional or, in the case of obvious emergency, to a "Centre 15" emergency call centre or the nearest hospital. Mesdocteurs.com is based on a simple promise: it enables users to ask a doctor a question anonymously or to talk to a doctor online via its website or mobile app.
After an initial four-month beta-testing phase, the site has had promising results with more than 1,000 questions handled by more than 60 partner doctors.
The purpose of the fund raising is to provide the start-up with the resources it needs to become the leading French online health advice service by :
- Strengthening its teams: based on their digital entrepreneurial experience, the founders have built up a team of six people who are experts in webmarketing and web development. They aim to hire six more people by next summer.
- Developing the offering: the start-up plans to: (i) launch a B2B service aimed at insurance companies and mutual organisations, (ii) set up a video/audio chat line, (iii) make the app available on Android and (iv) obtain the various approvals needed to offer users an online consultation service in the next few months.
Séverine Grégoire, co-founder of mesdocteurs.com, commented : "At present there is no alternative between the emergency services and your GP. We are not trying to replace either of these. Our aim is to provide users with a solution to stop them from self-diagnosing on the web and self-medicating, which can have serious consequences for their health."
François-Xavier Dedde, Tech Principal at Omnes Capital, added : "This investment illustrates our strategy of supporting serial entrepreneurs with whom we have worked successfully in the past. The deal represents a further investment in the health & digital sector, where our expertise in both Life Sciences and IT will be genuine strengths in supporting mesdocteurs.com in its development plans."
Romain Lavault, General Partner at Partech Ventures, said : "Following our investments in Klara in Germany and Push Doctor in the United Kingdom, we are proud to support the experienced MesDocteurs team, whose approach is particularly suited to the French market. When faced with a distressing health issue, most patients or their families do not have access to immediate and reliable personal input from a specialist. MesDocteurs meets this universal need through its mobile app and website, where patients and doctors can talk together confidentially and anonymously either before or in parallel with a traditional medical approach."
About Omnes Capital
Omnes Capital is a major player in private equity and infrastructure. With €2.1 billion in assets under management, Omnes capital provides companies with the capital needed to finance their growth and with key expertise in a number of areas: Buyout & Growth Capital, Private Debt, Venture Capital, Renewable Energy, Co-Investment, Secondary Funds of Funds. Omnes Capital was a subsidiary of Crédit Agricole until March 2012. The firm is now owned by its employees.
Omnes Capital is a signatory to the United Nations Principles for Responsible Investment (PRI).
Further information: www.omnescapital.com
About Partech Ventures :
Partech Ventures is a transatlantic venture capital firm with offices in Silicon Valley, Paris and Berlin. It invests in high-growth digital and tech companies from seed to growth through three families of funds: Partech Entrepreneur for seed capital, Partech International for venture capital and Partech Growth for growth capital. It has substantial experience in international business development. Since its foundation, Partech Ventures has completed 21 IPOs and more than 50 trade sales of over USD 100 million to large international corporations. The independent research firm Preqin has ranked Partech Ventures as one of the top ten venture capital funds in the world and the only European firm among the top twenty-five.
Gaëlle de Montoussé, email@example.com – +33 1 80 48 79 16
Caroline Babouillard, firstname.lastname@example.org – +33 1 44 50 58 72
Alexis Bollaert 06 63 73 82 97 email@example.com
Xavier Desmaison 06 82 92 44 50 firstname.lastname@example.org